FDA Acknowledges Corrections, Sends Optovue Warning Letter

Devices & Diagnostics Letter
A A
Although Optovue is taking corrective action to bring a normative database used with its RTVue optical coherence tomography into compliance, it received a warning letter that notes the effectiveness of the corrections can’t be fully reviewed and evaluated because they are ongoing.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $10.00